Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, LEMAITRE VASCULAR, INC. reported revenue of $250M, up 13.5% year over year. Operating margin was 27.2% and net margin 23.1%, on a free-cash-flow margin of 29.8% with capital expenditure at 2.7% of revenue. Every figure is computed directly from LMAT's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $250M | 27.2% | 23.1% |
| FY2024 | $220M | 23.8% | 20.0% |
| FY2023 | $193M | 19.0% | 15.6% |
| FY2022 | $162M | 16.6% | 12.8% |
| FY2021 | $154M | 23.6% | 17.4% |
How does LMAT compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: A · ACHR · AEHR · AERG · AEVA · AIRI
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.